Novartis Ag (NVS) Equity Income (2009 - 2026)

Novartis Ag (NVS) has 16 years of Equity Income data on file, last reported at -$3.0 million in Q1 2026.

• Quarterly Equity Income changed 0.0% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$8.0 million (up 11.11% YoY) and the FY2025 annual result came in at $1.0 million, changed 0.0% from the prior year.
• Equity Income fell to -$3.0 million in Q1 2026 per NVS's latest filing, from -$2.0 million in the prior quarter.
• The five-year high for Equity Income was $1.0 million in Q2 2022, with the low at -$29.0 million in Q1 2024.
• Average Equity Income over 5 years is -$3.8 million, with a median of -$3.0 million recorded in 2022.
• Year-over-year, Equity Income jumped 150.0% in 2023 and sank 3000.0% in 2024.
• Novartis Ag's Equity Income stood at -$3.0 million in 2022, then slumped by 100.0% to -$6.0 million in 2023, then surged by 50.0% to -$3.0 million in 2024, then surged by 33.33% to -$2.0 million in 2025, then tumbled by 50.0% to -$3.0 million in 2026.
• Business Quant data shows NVS's Equity Income at -$3.0 million in Q1 2026, -$2.0 million in Q4 2025, and -$4.0 million in Q3 2025.